Ultrasound-Guided Cytology of Spleen and Liver: A Prognostic Tool in Canine Cutaneous Mast Cell Tumor
- 1 September 2009
- journal article
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 23 (5) , 1051-1057
Abstract
Background: In the clinical staging of cutaneous mast cell tumors (cMCT), the diagnosis of metastasis is controversial based on cytological examination of lymph nodes, spleen, liver, bone marrow, and blood. Objectives: To define the prognostic role of ultrasound-guided cytology of spleen and liver in cMCT. The results of cytological evaluation were compared in relation with survival time. Animals: Fifty-two client-owned dogs with a diagnosis of cMCT. Methods: Selection of cases was based on cytological evaluation of liver and spleen to detect infiltration at distant sites. The Kaplan Meier method was used to compare survival in dogs with and without infiltration of spleen and liver (log-rank test P < .05). Results: Ten dogs with cMCT had mast cell infiltration of spleen, liver, or both and 4 of these dogs had involvement of the regional lymph nodes. The majority of dogs had 2 or more ultrasonographically abnormal findings simultaneously in spleen and liver. Nine dogs had grade II cMCT, and 1 had grade III cMCT. Dogs with positive evidence of mast cell infiltration to spleen, liver, or both had shorter survival times (34 versus 733 days) compared with dogs negative for mast cell infiltration at distant sites. Conclusion and Clinical Importance: Dogs with evidence of mast cell infiltration at distant sites have a shorter survival times than dogs without evidence of infiltration at distant sites. This study suggests that cytology of spleen and liver is indicated either for ultrasonographically normal or for ultrasonographically abnormal spleen and liver in dogs with cMCT.Keywords
This publication has 34 references indexed in Scilit:
- Clinicopathological Features and Outcome for Dogs with Mast Cell Tumors and Bone Marrow InvolvementJournal of Veterinary Internal Medicine, 2008
- Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997–2004)Veterinary and Comparative Oncology, 2007
- Advances in the diagnosis and management of cutaneous mast cell tumours in dogsJournal of Small Animal Practice, 2007
- Correlation of ultrasonographic appearance of lesions and cytologic and histologic diagnoses in splenic aspirates from dogs and cats: 32 cases (2002–2005)Journal of the American Veterinary Medical Association, 2007
- Cytological comparison of fine‐needle aspirates of liver and spleen of normal dogs and of dogs with cutaneous mast cell tumours and an ultrasonographically normal appearing liver and spleenVeterinary and Comparative Oncology, 2006
- Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998–2004)Journal of the American Veterinary Medical Association, 2006
- Canine Mast Cell Tumors: Correlation of Apoptosis and Proliferation Markers with PrognosisJournal of Veterinary Internal Medicine, 2006
- Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgeryAustralian Veterinary Journal, 2003
- Biologic Behavior and Prognostic Factors for Mast Cell Tumors of the Canine Muzzle: 24 Cases (1990–2001)Journal of Veterinary Internal Medicine, 2003
- Relationship of Disease Progression and Plasma Histamine Concentrations in 11 Dogs with Mast Cell TumorsJournal of Veterinary Internal Medicine, 2003